The ETS Inhibitors YK-4-279 and TK-216 Are Novel Antilymphoma Agents-Reference-Cited by-同舟云学术

The ETS Inhibitors YK-4-279 and TK-216 Are Novel Antilymphoma Agents

Published:2019-06-10 Issue:16 Volume:25 Page:5167-5176
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Spriano Filippo,Chung Elaine Yee Lin,Gaudio Eugenio,Tarantelli Chiara,Cascione Luciano,Napoli Sara,Jessen Katti,Carrassa Laura,Priebe Valdemar,Sartori Giulio,Graham Garrett,Selvanathan Saravana P.,Cavalli Andrea,Rinaldi Andrea,Kwee Ivo,Testoni Monica,Genini Davide,Ye B. Hilda,Zucca Emanuele,Stathis Anastasios,Lannutti Brian,Toretsky Jeffrey A.,Bertoni Francesco

Funder

Leukemia and Lymphoma SocietyLeukemia and Lymphoma Society (LLS)

OncosuisseOncosuisse (OCS)

Gelu Foundation

Associazione Italiana per la Ricerca sul CancroAssociazione Italiana per la Ricerca sul Cancro (AIRC)

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lactate-upregulated ARG2 expression induces cellular senescence in fibroblast-like synoviocytes of osteoarthritis via activating the mTOR/S6K1 signaling pathway;International Immunopharmacology;2024-12

2. A targeted CRISPR screen identifies ETS1 as a regulator of HIV latency;2024-08-03

3. Gene signatures of copper metabolism related genes may predict prognosis and immunity status in Ewing’s sarcoma;Frontiers in Oncology;2024-07-09

4. Novel markers of MCL1 inhibitor sensitivity in triple-negative breast cancer cells;Journal of Biological Chemistry;2024-06

5. Eukaryotic initiation factor 3a promotes the development of diffuse large B-cell lymphoma through regulating cell proliferation;BMC Cancer;2024-04-08